Evidence map›Paper›PMID 42763391›Full record

ArticleExperimental hematology & oncology2026

Comparison of haploidentical, matched sibling and matched unrelated donor allo-HCT in adult patients with AML in complete remission with measurable residual disease: a study from the Global committee and the ALWP of the EBMT.

Yishan Ye, Jacques-Emmanuel Galimard, Myriam Labopin, Francis Ayuk, Ibrahim Yakoub-Agha, Matthias Stelljes, Urpu Salmenniemi, Thomas Schroeder, Gesine Bug, Maria-Pilar Gallego-Hernanz and 16 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental hematology & oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Yishan YeBone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, China.
Jacques-Emmanuel GalimardEBMT Paris Study Unit, Paris, France.
Myriam LabopinEBMT Paris Study Unit, Paris, France.
Francis AyukUniversity Hospital Eppendorf, Hamburg, Germany.
Ibrahim Yakoub-AghaCentre Hospitalier Universitaire de Lille, Lille, France.
Matthias StelljesUniversity of Münster, Münster, Germany.
Urpu SalmenniemiHUCH Comprehensive Cancer Center, Helsinki, Finland.
Thomas SchroederUniversity Hospital Essen, Essen, Germany.
Gesine BugUniversity Hospital Frankfurt - Goethe University, Frankfurt am Main, Germany.
Maria-Pilar Gallego-HernanzHôpital La Milétrie, Poitiers, France.
Edouard ForcadeCentre Hospitalier Universitaire de Bordeaux, Hôpital Haut-Lévêque, Pessac, France.
Jakob PasswegUniversity Hospital Basel, Basel, Switzerland.
Maija Itala-RemesTurku University Hospital, Turku, Finland.
Simona PiemonteseHaematology and BMT, IRCCS Ospedale San Raffaele s.r.l., Milan, Italy.
Jaime SanzUniversity Hospital La Fe, Valencia, Spain.
Ali BazarbachiAmerican University of Beirut, Beirut, Lebanon.
Arnon NaglerChaim Sheba Medical Center, Tel Hashomer, Israel.
Eolia BrissotService d'Hématologie Clinique et de Thérapie Cellulaire, Sorbonne University, Hôpital Saint Antoine, APHP, 184 rue du Faubourg Saint-Antoine, Paris, 75012, France.
Lin LiBone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, China.
Yi LuoBone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, China.
Jimin ShiBone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, China.
Yanmin ZhaoBone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, China.
Mohamad MohtyService d'Hématologie Clinique et de Thérapie Cellulaire, Sorbonne University, Hôpital Saint Antoine, APHP, 184 rue du Faubourg Saint-Antoine, Paris, 75012, France.
He HuangBone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, China. hehuangyu@126.com.
Fabio CiceriHaematology and BMT, IRCCS Ospedale San Raffaele s.r.l., Milan, Italy. ciceri.fabio@hsr.it.
Norbert Claude GorinEBMT Paris Study Unit, Paris, France. gorinclaude@gmail.com.

Funding

National Key Research and Development Program of China 2025YFE0151000Zhejiang University Global Partnership Fund 188170*194252406/003
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute myeloid leukemiaAllogeneic hematopoietic cell transplantationDonor selectionMeasurable residual disease

Identifiers

PMID42763391
PMCPMC13589360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.